Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis

Experimental Biology and Medicine

Volumn 238, Issue 7, 2013, Pages 733-743

  McLaughlin, Patricia J ^a   Immonen, Jessica A ^a   Zagon, Ian S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; cutaneous wound repair; mast cells; naltrexone; smooth muscle actin; type 1 diabetes; vascular endothelial cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; FIBROBLAST GROWTH FACTOR 2; NALTREXONE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CONTROLLED STUDY; GRANULATION TISSUE; HISTOPATHOLOGY; IMMUNOREACTIVITY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MAST CELL; NONHUMAN; RAT; SKINFOLD THICKNESS; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ANGIOGENESIS; CUTANEOUS WOUND REPAIR; MAST CELLS; NALTREXONE; SMOOTH MUSCLE ACTIN; TYPE 1 DIABETES; VASCULAR ENDOTHELIAL CELLS;

ACTINS; ADMINISTRATION, TOPICAL; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CELL COUNT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FIBROBLAST GROWTH FACTOR 2; HYPERGLYCEMIA; INFLAMMATION; MALE; MAST CELLS; NALTREXONE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; SKIN; STREPTOZOCIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84884199416     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213492688     Document Type: Article

References (25)

1. McLaughlin PJ,Pothering CA,Immonen JA,Zagon IS.Topical treatment with the opioid antagonist naltrexone facilitates closure of full-thickness wounds in diabetic rats.Exp Biol Med. 2011;236:1122-32.
2. Zagon IS,Wu Y,McLaughlin PJ.The opioid growth factor, [Met5]-enkephalin, and the ζ (zeta) opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis.J Invest Dermatol. 1996;106:490-7.
3. Zagon IS,Jenkins JB,Sassani JW,Wylie JD,Ruth TB,Fry JL,Lang CM,McLaughlin PJ.Naltrexone, an opioid antagonist, facilitates re-epithelialization of the cornea in diabetic rat.Diabetes. 2002;51:3055-62.
4. Zagon IS,Essis FM,Verderame MF,Healy DA,Atnip RG,McLaughlin PJ.Opioid growth factor inhibits intimal hyperplasia in balloon-injured rat carotid artery.J Vasc Surg. 2003;37:636-43.
5. Blebea J,Mazo JE,Kihara TK,Vu JH,McLaughlin PJ,Atnip RG,Zagon IS.Opioid growth factor modulates angiogenesis.J Vasc Surg. 2000;32:364-73.
6. Timmers K,Voyles NR,Zalenski C,Wilkins S,Recant L.Altered β-endorphin, met- and leu-enkephalins, and enkephalin-containing peptides in pancreas and pituitary of genetically obese diabetic (db/db) mice during development of diabetic syndrome.Diabetes. 1986;35:1143-51.
7. Negri M,Tonnarini G,D'Alessandro M,Fallucca F.Plasma met-enkephalin in type 1 diabetes.Metabolism. 1992;41:460-1.
8. Fallucca F,Tonnarini G,De Biase N,D'Alessandro M,Negri M.Plasma met-enkephalin levels in diabetic patients: influence of autonomic neuropathy.Metabolism. 1996;45:1065-8.
9. Pieper GM,Mizoguchi H,Ohsawa M,Kamel J,Nagase H,Tseng LF.Decreased opioid-induced antinociception but unaltered G-protein activation in the genetic-diabetic NOD mouse.Eur J Pharmacol. 2000;401:375-9.
10. Cheng B,Liu H-W,Fu X-B,Sheng Z-Y,Li J-F.Coexistence and upregulation of three types of opioid receptors, mu, delta and kappa, in human hypertrophic scars.Clin Lab Invest. 2008;158:713-20.
11. Wintzen M,de Winter S,Out-Luiting JJ,van Duinen SG,Vermeer BJ.Presence of immunoreactive beta-endorphin in human skin.Exp Dermatol. 2001;10:305-11.
12. Bigliardi-Qi M,Gaveriaux-Ruff C,Pfaltz K,Bady P,Baumann T,Rufli T,Kieffer BL,Bigliardi PL.Deletion of δ-opioid receptor in mice alters skin differentiation and delays wound healing.Differentiation. 2006;74:174-85.
13. Nissen JB,Kragballe K.Enkephalins modulate differentiation of normal human keratinocytes in vitro.Exp Dermatol. 1997;6:222-9.
14. Zagon IS,Sassani JW,Kane ER,McLaughlin PJ.Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor.Brain Res. 1997;759:92-102.
15. Zagon IS,Sassani JW,McLaughlin PJ.Opioid growth factor modulates corneal epithelial growth in tissue culture.Am J Physiol. 1995;268:R942-R950.
16. Cheng F,McLaughlin PJ,Verderame MF,Zagon IS.The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation.Mol Biol Cell. 2009;20:319-27.
17. van der Loos CM,Meijer-Jorna LB,Broekmans ME,Ploegmakers HP,Teeling P,de Boer OJ,van der Wal AC.Anti-human vascular endothelial growth factor (VEGF) antibody selection for immunohistochemical staining of proliferating blood vessels.J Histochem Cytochem. 2010;58:109-18.
18. Zafirellis K,Agrogiannis G,Zachaki A,Gravani K,Karameris A,Kombouras C.Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer.J Surg Res. 2008;147:99-107.
19. Skalli O,Pelte MF,Peclet MC,Gabbiani G,Gugliotta P,Bussolati G,Ravazzola M,Orci L.Alphas-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes.J Histochem Cytochem. 1989;37:315-21.
20. Lee TY,Gotlieb AI.Early stages of endothelial wound repair: conversion of quiescent to migrating endothelial cells involves tyrosine phosphorylation and actin microfilament reorganization.Cell Tissue Res. 1999;297:435-50.
21. Li H,Xiaobing F,Zhang L,Huang Q,Wu Z,Sun T.Research of PDGF-BB gel on the wound healing of diabetic rats and its pharmacodynamics.J Surg Res. 2008;145:41-8.
22. Pietramaggiori G,Scherer SS,Mathews JC,Gennaoui T,Lancerotto L,Ragno G,Valeri CR,Orgill DP.Quiescent platelets stimulate angiogenesis and diabetic wound repair.J Surg Res. 2010;160:169-77.
23. Al-Mulla F,Leibovich SJ,Francis IM,Bitar MS.Impaired TGF-β signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes.Mol Biosyst. 2011;7:3005-20.
24. Marrotte EJ,Chen D-D,Hakim JS,Chen AF.Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice.J Clin Invest. 2010;120:4207-19.
25. Dasu MR,Thangappan RK,Bourgette A,DiPietro LA,Isseroff R,Jialal I.TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice.Lab Invest. 2010;90:1628-36.